BIO-Europe Spring 2026: partnership event brings funding hope to biotechs
The BIO-Europe Spring 2026 conference in Lisbon brought together over 3,700 life sciences innovators to discuss potential collaborations and fundraising opportunities. The event offered a platform for biotechs to seek licensing deals and funding, with many expressing optimism about the current funding landscape in Europe.
BIO-Europe Spring 2026 was held in Lisbon, Portugal, with over 3,700 attendees. The conference provided a space for biotechs to forge partnerships and seek funding. Many companies were looking for licensing deals and funding, despite the challenging funding landscape in recent years. The event offered a platform for companies to showcase their research and services. Biotechs like Vesper Bio were hopeful about finding partners and investors. The conference highlighted the growth of the life sciences industry in Europe, particularly in southern countries like Portugal, Spain, and Italy.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.